In a microcytotoxicity assay we tested lymphocyte cytotoxicity against autologous hepatocytes. The following cytotoxicity values were found (given mean ± SEM): acute non-A, non-B (NANB) hepatitis 45 7±4 3% (n=7), chronic NANB hepatitis 32*8±5*1% (n=11), chronic active hepatitis B (CAH-B) 27-7±6-7% (n=10), toxic lesions 18-1±4*2% (n=18), controls with normal liver histology or minimal changes 4 9±2 5% (n=8). Thus our study shows enhanced cellular cytotoxicity in acute and chronic NANB hepatitis and indicates that T cells as well as non-T cells have cytotoxic effector functions. These findings are similar to those obtained in CAH-B and suggest that cellular immune reactions play an important role in the course of NANB hepatitis. For comparison we tested cytotoxic reactions in toxic lesions. They were only moderate and well distinguishable from those observed in NANB hepatitis and CAH-B; they even may be unspecific. No correlation was seen between cytotoxicity and aminotransferase concentrations.
SUMMARY
In a microcytotoxicity assay we tested lymphocyte cytotoxicity against autologous hepatocytes. The following cytotoxicity values were found (given mean ± SEM): acute non-A, non-B (NANB) hepatitis 45 7±4 3% (n=7), chronic NANB hepatitis 32*8±5*1% (n=11), chronic active hepatitis B (CAH-B) 27-7±6-7% (n=10), toxic lesions 18-1±4*2% (n=18), controls with normal liver histology or minimal changes 4 9±2 5% (n=8). Thus our study shows enhanced cellular cytotoxicity in acute and chronic NANB hepatitis and indicates that T cells as well as non-T cells have cytotoxic effector functions. These findings are similar to those obtained in CAH-B and suggest that cellular immune reactions play an important role in the course of NANB hepatitis. For comparison we tested cytotoxic reactions in toxic lesions. They were only moderate and well distinguishable from those observed in NANB hepatitis and CAH-B; they even may be unspecific. No correlation was seen between cytotoxicity and aminotransferase concentrations.
There is convincing evidence now that the course of hepatitis B virus infections is determined by the host's immune reactions, mainly the cellular immune response1-nevertheless the target antigens and the effector cells for these reactions are still controversial. Therefore selection of an appropriate target cell system seems to be important. The use of autologous hepatocytes as targets2-7 hopefully will help to overcome some of the difficulties with allogeneic target systems such as differences in expression of alloantigens and other surface antigens.
Up until now enhanced cytotoxicity against autologous hepatocytes has been reported in small series of acute and chronic viral hepatitis,4 7 chronic active HBsAG-negative (presumably mainly autoimmune type) hepatitis5 and chronic active hepatitis B.2 6 Similar investigations in patients with liver diseases which are not believed to be mediated by immune reaction have not been reported, although they may help to establish the immunologic specificity of those phenomena. Until a detailed characterisation of viral antigens in NANB hepatitis will be available this autologous test system seems to be the most promising one to study cellular immune reactions in NANB virus infection.
We therefore studied cellular cytotoxicity against autologous hepatocytes in patients with acute and chronic NANB hepatitis, chronic active hepatitis B and compared the findings with results in toxic lesions and normal controls.
Methods

PATIENTS
The following groups of patients were tested: (a) Seven Twenty four hours after the incubation of\ the hepatocytes had been started the supernatant was aspirated from the wells and replaced by 10 ul of a lymphocyte suspension. At least 10 wells were filled with each of the lymphocyte preparations tested. Except for some experiments mentioned below effector/target cell ratio was 300:1. Adding medium without lymphocytes to 10-20 wells provided individual control values. After incubation for further 18 hours the plates were inverted for two hours and washed carefully, fixed with methanol, and stained with 1% eosin. Hepatocytes remaining in each well were counted and cytotoxicity was calculated according to the formula:
(number of cells in test wells 1 number of cells in control wells 1 = % cytotoxicity Cytotoxicity assay was performed before diagnosis of the patient was known. Unlike Vergani32 we reduced the incubation period to 18 hours to minimise unspecific effects, as during this time T cell mediated as well as K and NK mediated cytotoxicity should have reached its maximum.9
STATISTICS
The exact Wilcoxon-Mann-Whitney test was used to compare two groups of patients. 1( For calculation of significances we applied the Holm's procedure,' which simultaneously controls the error probability for all the tests used. As error probability we chose 5%. For some additional questions p values were calculated and interpreted descriptively.
Results
SPONTANEOUS LOSS OF HEPATOCYTES DURING THE INCUBATION PERIOD
At the end of the incubation period the number of hepatocytes remaining in the control wells was very similar in acute NANB hepatitis, chronic active hepatitis B as well as in the control group (Table 1) . 
CYTOTOXIC ACTIVITY OF LYMPHOCYTE COMPARTMENTS
Cytotoxic activity was found in T cell enriched as well as in non-T cell enriched lymphocytes in all the diseases investigated. In most cases we found only minor differences between unseparated lymphocytes and T enriched or T depleted lymphocytes. In acute NANB hepatitis non-T cell enriched lymphocytes were less effective than T cell enriched fractions, while in the other groups non-T cell enriched fractions tended to have higher cytotoxic activity than T cell enriched lymphocytes (Table 2 and Fig. 3 ). 
EFFECT OF MACROPHAGES AND MONOCYTES
In a number of cases cytotoxic activity of peripheral blood mononuclear cells including lymphocytes and macrophages and monocytes was compared with the effect of lymphocytes lone. While in chronic NANB hepatitis there was no additional cytotoxic effect of macrophages and monocytes detectable, in toxic lesions these effectors remarkably enhanced the cytotoxic reactions (p<001, Table 3 ).
EFFECT OF DIMINISHED NUMBER OF EFFECTOR CELLS
While we usually used an effector/target cell ratio of 300:1 in some experiments we were able to titrate the effector/target cell ratio. A reduction of the number of lymphocytes led to a proportional decrease in cytotoxic activity, eventually reaching background level cytotoxicity seen in normal controls (Fig. 4) .
CORRELATION BETWEEN CYTOTOXICITY AND AMINOTRANSFERASE CONCENTRATIONS
The cytotoxicity we found did not correlate with aminotransferase or bilirubin concentrations. 4 Cellular cytotoxicity against autologous hepatocytes at various effectorltarget cell ratios (mean ± SEM).
Discussion
The use of autologous hepatocytes as target cells for studies of cellular cytotoxicity has some clear advantages and some disadvantages in comparison with the use of animal hepatocytes, cultured cell lines, or target cells coated with certain antigens. First this test system provides HLA identity between target auid effector cells. There is increasing evidence now that this identity is a prerequisite for T cell cyto- suitable for chromium release assays, comparative studies indicate a good correlation between microcytotoxicity assay and chromium release under similar experimental conditions. 16 More detailed analysis revealed that in a microcytotoxicity assay some cells may still attach to the culture plates which do not satisfy other criteria of cell viability,'7 so that the cytotoxicity measured in our study might rather by underestimated than overestimated. The low cytotoxicity values in our control group and the decline of cytotoxic activity with the reduction of the number of effector cells in patients with The cytotoxic reactions in patients with toxic lesions found in our study were easily distinguishable from those seen in patients with viral hepatitis and did not exceed mean plus two standard deviations of the controls. The cytotoxicity found in this group of patients probably reflects unspecific effects because of increased fat content or other toxic changes that could impair the ability of these cells to attach to the culture plates. The role of macrophages and monocytes which seem to enhance cytotoxic reactions in this disease is far from clear, as recent studies could show cytotoxic36 as well as inhibitory effects of these cells.37
In conclusion patients with acute and chronic NANB hepatitis exhibited enhanced cytotoxicity. The observation that T lymphocytes are the predominant effector cells in acute infection, whereas non-T cells are predominant in chronic hepatitis suggests that effector mechanisms in acute and chronic NANB hepatitis may be different. 
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